Valiant Organics Board of Directors
Get the latest insights into the leadership at Valiant Organics. Learn about the experienced professionals guiding the company's strategy and governance.
| Name | Position |
|---|---|
| Mr. Chandrakant V Gogri | Chairman Emeritus |
| Mr. Navin C Shah | Chairman & Ind.Director |
| Mr. Sathiababu K Kallada | Managing Director |
| Mr. Parimal H Desai | Managing Director |
| Mr. Mahek M Chheda | Executive Director |
| Mr. Nemin M Savadia | Executive Director |
| Mr. Siddharth D Shah | Executive Director |
| Mr. Santosh S Vora | Non Executive Director |
| Dr. Kiritkumar H Desai | Non Executive Director |
| Mrs. Sonal A Vira | Independent Director |
| Mr. Paras S Savla | Independent Director |
| Dr. Sudhirprakash B Sawant | Independent Director |
Valiant Organics FAQs
The board at Valiant Organics consists of experienced professionals, including Mr. Chandrakant V Gogri , Mr. Navin C Shah , and others, overseeing the company’s strategic and corporate governance.
Directors at Valiant Organics are typically nominated by the Nomination and Remuneration Committee and approved by shareholders, adhering to regulatory and governance standards. While this is the standard procedure, the exact process may differ depending on the company’s internal policies and governance framework.
As of the latest update, Mr. Chandrakant V Gogri is the current chairman at Valiant Organics.
Executive directors at Valiant Organics are involved in day-to-day operations, while non-executive directors, including independents, provide oversight and strategic input. While this distinction is generally followed, the specific responsibilities of executive and non-executive directors may vary based on the company’s organisational structure and governance practices.
Yes, Valiant Organics adheres to all applicable SEBI and Companies Act provisions related to board structure, diversity, and independence.
At Valiant Organics, board members usually serve fixed terms as outlined in the company’s charter or governance policy, commonly ranging between three to five years, with the possibility of renewal based on performance, shareholder approval, and regulatory norms.
